TrialBlood advances2021
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma.
Constantine S Tam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
59 papers cite it
this paperpooled ittrialcites it
TrialBlood advances2021
Constantine S Tam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.